{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:44:19Z","timestamp":1794667459040,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.149139","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:44:34Z","timestamp":1763646274000},"page":"149139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Experimental evaluation of the therapeutic effect of niosomal miltefosine delivered via Polyvinylpyrrolidone - hyaluronic acid microneedle patches against Leishmania major"],"prefix":"10.1016","volume":"334","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7603-8507","authenticated-orcid":false,"given":"Naghmeh","family":"Dastan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7396-9371","authenticated-orcid":false,"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-4793","authenticated-orcid":false,"given":"Gholamreza","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6407-2976","authenticated-orcid":false,"given":"Seyed Mousa","family":"Motavallihaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-9446","authenticated-orcid":false,"given":"Amin","family":"Derakhshanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Ardeshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6066-3074","authenticated-orcid":false,"given":"Ali Mohammad","family":"Tamaddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.149139_bb0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Res"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149139_bb0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/pathogens11080921","article-title":"Non-endemic Leishmaniases reported globally in humans between 2000 and 2021\u2014a comprehensive review","volume":"11","author":"Rocha","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.snb.2016.05.023","article-title":"Gold nanoparticles-based biosensing of Leishmania major kDNA genome: visual and spectrophotometric detections","volume":"235","author":"Sattarahmady","year":"2016","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100239","article-title":"Leishmaniasis: a multifaceted approach to diagnosis, maladies, drug repurposing and way forward","author":"Makarani","year":"2025","journal-title":"The Microbe."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149139_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149139_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/2156587215623435","article-title":"Antileishmanial activities of Greek Juniper (Juniperus excelsa M.Bieb.) against Leishmania major promastigotes","volume":"22","author":"Moein","year":"2017","journal-title":"J Evid Based Complementary Altern Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2025.149139_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.micres.2014.02.009","article-title":"Treatment of infectious disease: beyond antibiotics","volume":"169","author":"Nigam","year":"2014","journal-title":"Microbiol. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149139_bb0050","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1021\/acsinfecdis.9b00275","article-title":"Tandem mass tag proteomic analysis of in vitro and in vivo models of cutaneous Leishmaniasis reveals parasite-specific and nonspecific modulation of proteins in the host","volume":"5","author":"Negrao","year":"2019","journal-title":"ACS Infect Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149139_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MJT.0b013e3181822e90","article-title":"Current treatment for cutaneous leishmaniasis: a review","volume":"16","author":"Palumbo","year":"2009","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0065","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149139_bb0070","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149139_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajme.2012.04.003","article-title":"Miltefosine for Old World cutaneous leishmaniasis: an experimental study on Leishmania major infected mice","volume":"48","author":"Eissa","year":"2012","journal-title":"Alexandria J. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149139_bb0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jps.1023","article-title":"Trends and developments in liposome drug delivery systems","volume":"90","author":"Lian","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149139_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061152","article-title":"Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems","volume":"14","author":"Alkilani","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0095","first-page":"66","article-title":"Review on: recent trend on transdermal drug delivery system","volume":"2","author":"Shingade","year":"2012","journal-title":"J. Drug Deliv. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: a review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149139_bb0105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/s19051028","article-title":"Current advancements in transdermal biosensing and targeted drug delivery","volume":"19","author":"Pandey","year":"2019","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/IJN.S289443","article-title":"Nanocarriers-mediated drug delivery Systems for Anticancer Agents: an overview and perspectives","volume":"16","author":"Edis","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149139_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/abm-2018-0002","article-title":"Niosomes: a review of their structure, properties, methods of preparation, and medical applications","volume":"11","author":"Yeo","year":"2017","journal-title":"Asian Biomed."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s43094-020-00117-y","article-title":"Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug","volume":"6","author":"Durga","year":"2020","journal-title":"Future J Pharm Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149139_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.22270\/jddt.v8i6.2029","article-title":"Noisomes: as novel vesicular drug delivery system","volume":"8","author":"Ray","year":"2018","journal-title":"Journal of Drug Delivery and Therapeutics."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12896-024-00874-1","article-title":"Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections","volume":"24","author":"Hemmati","year":"2024","journal-title":"BMC Biotechnol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149139_bb0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149139_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082119","article-title":"Advances and prospects for hydrogel-forming microneedles in transdermal drug delivery","volume":"11","author":"Hou","year":"2023","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.149139_bb0145","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40824-022-00302-5","article-title":"Film-trigger applicator (FTA) for improved skin penetration of microneedle using punching force of carboxymethyl cellulose film acting as a microneedle applicator","volume":"26","author":"Kim","year":"2022","journal-title":"Biomaterials Research."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2021.109485","article-title":"Synthesis and characterization of PVP microneedle patch using metal bioelectrodes for novel drug delivery system","volume":"201","author":"Yang","year":"2021","journal-title":"Mater. Des."},{"issue":"Pt 5","key":"10.1016\/j.ijbiomac.2025.149139_bb0160","article-title":"Microneedles based on hyaluronic acid-polyvinyl alcohol with antibacterial, anti-inflammatory, and antioxidant effects promote diabetic wound healing","volume":"282","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0165","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijbiomac.2021.05.075","article-title":"Dissolvable carboxymethyl cellulose\/polyvinylpyrrolidone microneedle arrays for transdermal delivery of amphotericin B to treat cutaneous leishmaniasis","volume":"182","author":"Zare","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2018.05.002","article-title":"Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes","volume":"185","author":"Nazari-Vanani","year":"2018","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.chemphyslip.2010.12.005","article-title":"Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions","volume":"164","author":"Wang","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0180","series-title":"Tropical Medicine & International Health","article-title":"Methods for characterization and identification of miltefosine in suspected substandard capsules","year":"2009"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.149139_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/nano12203570","article-title":"Formulation and evaluation of niosomal alendronate sodium encapsulated in polymeric microneedles: in vitro studies, stability study and cytotoxicity study","volume":"12","author":"Zaid Alkilani","year":"2022","journal-title":"Nanomaterials (Basel)."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.149139_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larraneta","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149139_bb0195","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/polym15081962","article-title":"Development and evaluation of an innovative approach using Niosomes based polymeric microneedles to deliver dual antioxidant drugs","volume":"15","author":"Zaid Alkilani","year":"2023","journal-title":"Polymers (Basel)."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149139_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006701","article-title":"Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin","volume":"12","author":"Khadir","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.msec.2017.05.143","article-title":"Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin","volume":"80","author":"Yu","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0210","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41598-024-52620-4","article-title":"Comparison of cytotoxicity of Miltefosine and its niosomal form on chick embryo model","volume":"14","author":"Seyedi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121211","article-title":"Strategy for osteoarthritis therapy: improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays","volume":"609","author":"Zhou","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1039\/C4TB01555J","article-title":"Fabrication of a novel partially dissolving polymer microneedle patch for transdermal drug delivery","volume":"3","author":"Lee","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149139_bb0225","first-page":"502","article-title":"Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis","volume":"42","author":"Pourmohammadi","year":"2011","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149139_bb0230","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4103\/1735-5362.327508","article-title":"Artemether-loaded nanostructured lipid carriers: preparation, characterization, and evaluation of in vitro effect on Leishmania major","volume":"16","author":"Rahnama","year":"2021","journal-title":"Res Pharm Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149139_bb0235","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12639-018-1018-7","article-title":"Preparation of meglumine antimonate loaded albumin nanoparticles and evaluation of its anti-leishmanial activity: an in vitro assay","volume":"42","author":"Barazesh","year":"2018","journal-title":"J. Parasit. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149139_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005957","article-title":"Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: a triple-blind randomized controlled clinical trial","volume":"11","author":"Parvizi","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149139_bb0245","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","article-title":"Miltefosine to treat leishmaniasis","volume":"6","author":"Berman","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0250","doi-asserted-by":"crossref","first-page":"018","DOI":"10.17352\/2455-5363.000009","article-title":"Application of nano drugs in treatment of leishmaniasis","volume":"2","author":"Shahcheraghi","year":"2016","journal-title":"Global Journal of Infectious Diseases and Clinical Research."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0260","article-title":"Niosomes: a novel carrier drug delivery system","volume":"11","author":"Arumugam","year":"2021","journal-title":"Journal of Drug Delivery & Therapeutics."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/08982104.2012.762519","article-title":"Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis","volume":"23","author":"Momeni","year":"2013","journal-title":"J. Liposome Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0270","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbamem.2006.01.023","article-title":"Preparation of submicron unilamellar liposomes by freeze-drying double emulsions","volume":"1758","author":"Wang","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149139_bb0275","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.2174\/1570180819666220816120305","article-title":"Cytotoxicity effects of Miltefosine and Niosomal form on human umbilical vein endothelial cells: colorimetric assay, apoptosis, and gene expression profiling","volume":"20","author":"Sharifi","year":"2023","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0280","series-title":"IOP Conference Series: Materials Science and Engineering","article-title":"Preparation of stable colloidal silica with controlled size nano spheres from sodium silicate solution","author":"Qomariyah","year":"2018"},{"issue":"02","key":"10.1016\/j.ijbiomac.2025.149139_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4236\/jbnb.2016.72011","article-title":"Effects of size and surface charge of polymeric nanoparticles on in vitro and in vivo applications","volume":"7","author":"Sadat","year":"2016","journal-title":"J. Biomater. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2020.e00156","article-title":"Nanoparticles: new agents toward treatment of leishmaniasis","volume":"10","author":"Nafari","year":"2020","journal-title":"Parasite epidemiology and control."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149139_bb0295","first-page":"97","article-title":"Nanoliposomal miltefosine for the treatment of cutaneous leishmaniasis caused by Leishmania major (MRHO\/IR\/75\/ER): the drug preparation and in vitro study","volume":"5","author":"Najafian","year":"2016","journal-title":"Int. J. Pharm. Res. Allied Sci."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0300","author":"Khan","year":"2020","journal-title":"A novel effective therapeutic approach for treatment of Leishmania tropica through Miltefosine Loaded Chitosan Nanoparticles."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149139_bb0305","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.intimp.2012.02.002","article-title":"Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9","volume":"12","author":"Mukherjee","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0310","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2173335","article-title":"Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of cutaneous leishmaniasis","volume":"30","author":"Anjum","year":"2023","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149139_bb0315","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/nano9121749","article-title":"Applications of nanomaterials in Leishmaniasis: a focus on recent advances and challenges","volume":"9","author":"Saleem","year":"2019","journal-title":"Nanomaterials (Basel)."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0320","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1080\/10717544.2022.2125600","article-title":"The most promising microneedle device: present and future of hyaluronic acid microneedle patch","volume":"29","author":"Kang","year":"2022","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149139_bb0325","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/09205063.2022.2155778","article-title":"PVP-microneedle array for drug delivery: mechanical insight, biodegradation, and recent advances","volume":"34","author":"Mangang","year":"2023","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149139_bb0330","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1039\/C6RA27476E","article-title":"Fabrication of two-layer dissolving polyvinylpyrrolidone microneedles with different molecular weights for in vivo insulin transdermal delivery","volume":"7","author":"Lee","year":"2017","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0335","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41467-017-01764-1","article-title":"Microneedle-array patches loaded with dual mineralized protein\/peptide particles for type 2 diabetes therapy","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.149139_bb0340","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/polym13172998","article-title":"Interaction between filler and polymeric matrix in nanocomposites: magnetic approach and applications","volume":"13","author":"Bustamante-Torres","year":"2021","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149139_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040579","article-title":"Design and evaluation of dissolving microneedles for enhanced dermal delivery of propranolol hydrochloride","volume":"13","author":"He","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149139_bb0350","doi-asserted-by":"crossref","DOI":"10.1007\/s10544-018-0355-8","article-title":"Microneedle-based delivery of amphotericin B for treatment of cutaneous leishmaniasis","volume":"21","author":"Nguyen","year":"2019","journal-title":"Biomed. Microdevices"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149139_bb0355","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/expr.1996.0098","article-title":"Leishmania major: effect of infectious dose on T cell subset development in BALB\/c mice","volume":"84","author":"Doherty","year":"1996","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119390","article-title":"A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization","volume":"586","author":"Lanza","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102185","article-title":"Evaluation the biological effect of niosomal hydrogel base amphotericin in combination with Artemisia sieberi essential oil for treatment of cutaneous leishmaniasis: in vitro and in vivo studies","volume":"15","author":"Ardeshiri","year":"2025","journal-title":"Results in Chemistry."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149139_bb0370","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2567.2003.01582.x","article-title":"Histopathological outcome of Leishmania major-infected BALB\/c mice is improved by oral treatment with N-acetyl-l-cysteine","volume":"108","author":"Rocha-Vieira","year":"2003","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149139_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous Leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2025.149139_bb0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","article-title":"T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant?","volume":"3","author":"Alexander","year":"2012","journal-title":"Front. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:43:36Z","timestamp":1781167416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025096965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":76,"alternative-id":["S0141813025096965"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149139","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental evaluation of the therapeutic effect of niosomal miltefosine delivered via Polyvinylpyrrolidone - hyaluronic acid microneedle patches against Leishmania major","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149139"}}